Article info

Download PDFPDF
Original article
Clinical relevance of detecting anti-infliximab antibodies with a drug-tolerant assay: post hoc analysis of the TAXIT trial

Authors

  1. Correspondence to Professor Ann Gils, Laboratory for Therapeutic and Diagnostic Antibodies, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven O&N II Herestraat 49, PO Box 820, Leuven B-3000, Belgium; ann.gils{at}pharm.kuleuven.be
View Full Text

Citation

Van Stappen T, Vande Casteele N, Van Assche G, et al
Clinical relevance of detecting anti-infliximab antibodies with a drug-tolerant assay: post hoc analysis of the TAXIT trial

Publication history

  • Received October 4, 2016
  • Revised April 7, 2017
  • Accepted April 9, 2017
  • First published April 27, 2017.
Online issue publication 
April 06, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.